$KALA
KALA BIO, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Arlington, MA
KALA chart
What traders are saying about $KALA
Latest postsKALA BIO, Inc. news
- KALA BIO, Inc. Narrows Preliminary Q3 Net Loss to About $0.8 Million
TOKENPOST ·
- Form 8K KALA BIO Inc For: 9 November By Investing.com
Investing.com UK ·
- Preliminary Q3 net loss narrows at KALA BIO (KALA), which expects a quarterly report around November 16.
Stock Titan ·
- Kala Bio reports 90% reduction in quarterly net loss By Investing.com
Investing.com Nigeria ·
- KALA BIO Provides CEO Update and Preliminary Third Quarter 2026 Financial Results
Yahoo Finance ·
- KALA BIO, Inc. (KALA) Reports Quarterly Net Loss Down Approximately 90% YoY
TradingView ·
- KALA BIO, Inc. (0JQ2.L) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- KALA BIO Stockholders Approve Key Corporate Proposals
TipRanks ·
- More than 14 million votes back reverse split authority for KALA BIO (KALA).
Stock Titan ·
- KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
Yahoo Finance ·
- Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
Yahoo Finance ·
- KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team
Yahoo Finance ·
KALA BIO, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$27.0M | -$38.5M | -$42.2M | -$44.8M |
| Diluted EPS | $-3.31 | $-10.15 | $-17.35 | $-29.48 |
| Total assets (year end) | $9.5M | $55.5M | $55.9M | $86.8M |
| Cash and equivalents (year end) | $7.6M | $51.2M | $50.9M | $70.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About KALA BIO, Inc.
- Ticker
- KALA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Arlington, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1479419
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Frequently asked questions
What exchange is KALA BIO, Inc. listed on?
KALA BIO, Inc. trades on the Nasdaq under the ticker symbol KALA.
What industry is KALA BIO, Inc. in?
KALA BIO, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is KALA BIO, Inc. headquartered?
KALA BIO, Inc.'s business address on file with the SEC is in Arlington, MA.
When does KALA BIO, Inc.'s fiscal year end?
KALA BIO, Inc.'s fiscal year ends on December 31.
How much revenue did KALA BIO, Inc. report?
KALA BIO, Inc. reported $0 in revenue for calendar year 2017, according to its SEC filings.